Vanguard Global Advisers’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$666K Sell
8,490
-2,351
-22% -$217K ﹤0.01% 1953
2026
Q2
$1.12M Buy
10,841
+3,875
+56% +$227K ﹤0.01% 1685
2026
Q1
$266K Buy
+6,966
New +$220K ﹤0.01% 2302

Other funds holding ATEX

Vanguard Global Advisers's ATEX Position: Q3 2026 in Review

Vanguard Global Advisers reduced its Anterix (ATEX) stake by 22% in Q3 2026, selling an estimated $217K and leaving 8,490 shares worth $666K. The position accounts for ﹤0.01% of the portfolio, ranked #1953.

Vanguard Global Advisers first reported a position in ATEX in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.12M in Q2 2026. 178 funds tracked by Wall St. Rank hold ATEX as of Q3 2026.

  • Vanguard Global Advisers held 8,490 shares of Anterix worth $666K as of Q3 2026.
  • Vanguard Global Advisers sold 2,351 Anterix shares in Q3 2026, an estimated $217K.
  • Anterix made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #1953 holding.
  • Vanguard Global Advisers first reported a position in Anterix in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Global Advisers's Anterix position peaked at $1.12M in Q2 2026.
  • 178 funds tracked by Wall St. Rank held Anterix as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.